Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human SET Antikörper:
anti-Mouse (Murine) SET Antikörper:
anti-Rat (Rattus) SET Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal SET Primary Antibody für WB - ABIN4620361
von Lindern, van Baal, Wiegant, Raap, Hagemeijer, Grosveld: Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene. in Molecular and cellular biology 1992
Show all 12 Pubmed References
Data show that PP32 and SET/TAF-Ibeta proteins block HAT1-mediated H4 acetylation.
Overexpression of SET-Nup214 (zeige NUP214 Antikörper) in HeLa cells leads to the formation of similar nuclear bodies that recruit CRM1 (zeige XPO1 Antikörper), export cargo proteins, and certain nucleoporins and concomitantly affect nuclear protein (zeige RDBP Antikörper) and poly(A)(+) RNA export.
Molecular chaperone (zeige HSP90AA1 Antikörper) SET-assisted eviction of linker histones and Shugoshins is a fundamental step in mammalian mitotic progression.
Our findings suggested the oncogenic role of SET and the adverse prognostic value of SET overexpression in hepatocellular carcinoma (HCC (zeige FAM126A Antikörper)). This alteration defines a subgroup of HCC (zeige FAM126A Antikörper) patients who could benefit from SET antagonists, such as EMQA.
This review summarizes and discusses the general mechanisms of H3K4 methylation, and how the six main enzymes from the SET/MLL (zeige MLL Antikörper) family (responsible for H3K4me1/me2 (zeige CELSR1 Antikörper)/me3 (zeige ME3 Antikörper)) function in hematopoiesis and in hematologic malignancies. [review]
identification of the oncoprotein SET as a major cellular factor whose binding with p53 (zeige TP53 Antikörper) is dependent on C-terminal domain acetylation status
Data indicate that SET protein as a direct target of microRNA miR (zeige MLXIP Antikörper)-125b, and the downregulation of SET, observed during tumor migration, was affected by the overexpression of miR125b.
significance of SET/I2PP2A-mediated PP2A (zeige PPP2R4 Antikörper) and non-PP2A (zeige PPP2R4 Antikörper) pathways in polycystic ovary syndrome
Data show that downregulating proto-oncogene (zeige RAB1A Antikörper) protein Akt (p-Akt (zeige AKT1 Antikörper)) by inhibiting PP2A (zeige PPP2R4 Antikörper) inhibitor SET-mediated protein phosphatase 2A (PP2A (zeige PPP2R4 Antikörper)) inactivation determined the pro-apoptotic effects of EMQA and paclitaxel combination treatment.
Data suggest a critical role for the I2PP2A protein (SET)-protein phosphatase-2A (PP2A) signaling axis in Pten protein (Pten) deficient castration resistant prostate cancer (CRPC) progression.
The presence of full-length SET in the neuronal cytoplasm is sufficient to impair PP2A (zeige PPP2R2B Antikörper) methylation and activity, leading to tau hyperphosphorylation.
SET/PP2A (zeige PPP2R2B Antikörper) system regulates testosterone production in ovarian follicles in vitro.
SET played a positive role in regulating ovarian androgen biosynthesis by enhancing the transcription of steroidogenic enzymes CYP17A1 (zeige CYP17A1 Antikörper) and HSD3B2 (zeige HSD3B2 Antikörper), which maybe contribute to the hyperandrogenism in polycystic ovary syndrome
study found SET, a putative oncogene (zeige RAB1A Antikörper) was significantly downregulated in a bisphenol A dose-dependent manner; from gene network analysis, SET is predicted to communicate with other genes including CYP17 (zeige CYP17A1 Antikörper), which is involved in biosynthesis and metabolism of sex-hormones
Our results suggest that the increased I(2)(PP2A (zeige PPP2R2B Antikörper)) may trigger apoptosis by p53 (zeige TP53 Antikörper) upregulation, but due to simultaneous activation of Akt (zeige AKT1 Antikörper), the neurons are aborted from the apoptotic pathway.
SET is an important regulator of chromosome condensation (zeige RCC1 Antikörper)/decondensation and that disruption of the MCPH1 (zeige MCPH1 Antikörper)-SET interaction might be important for the pathogenesis of primary microcephaly
By a novel molecular mechanism, apolipoprotein (apo)E (zeige APOE Antikörper)/peptide enhances protein phosphatase 2A (PP2A (zeige PPP2R2B Antikörper)) activity within a cell by binding/forming a complex with SET, reducing the amount of SET available to inhibit PP2A (zeige PPP2R2B Antikörper), signaling, and inflammatory response.
These studies indicated that the TAF (zeige TAF8 Antikörper)-Ialpha promoter is under the control of Sp1 (zeige SP1 Antikörper).(TAF (zeige TAF8 Antikörper)-Ialpha )
The protein encoded by this gene inhibits acetylation of nucleosomes, especially histone H4, by histone acetylases (HAT). This inhibition is most likely accomplished by masking histone lysines from being acetylated, and the consequence is to silence HAT-dependent transcription. The encoded protein is part of a complex localized to the endoplasmic reticulum but is found in the nucleus and inhibits apoptosis following attack by cytotoxic T lymphocytes. This protein can also enhance DNA replication of the adenovirus genome. Several transcript variants encoding different isoforms have been found for this gene.
protein phosphatase 2A inhibitor 2-like
, HLA-DR-associated protein II
, SET translocation (myeloid leukemia-associated)
, Template-Activating Factor-I, chromatin remodelling factor
, inhibitor of granzyme A-activated DNase
, inhibitor-2 of protein phosphatase-2A
, phosphatase 2A inhibitor I2PP2A
, protein SET
, protein phosphatase type 2A inhibitor
, SET translocation
, template-activating factor I
, liver regeneration-related protein LRRGR00002